End Cash: The amount of cash held by the company for the given period.
Tenax Therapeutics, Inc. (TENX) had End Cash of $99.37M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-15.80M |
|
-- |
|
-- |
|
$16.81M |
|
$-16.81M |
|
$1.00M |
|
$-15.80M |
|
$-15.80M |
|
$-15.80M |
|
$-15.80M |
|
$-15.80M |
|
$-15.80M |
|
$-16.81M |
|
$-16.81M |
|
39.74M |
|
39.74M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$102.81M |
|
-- |
|
-- |
|
$102.81M |
|
$6.60M |
|
-- |
|
-- |
|
$6.60M |
|
$96.21M |
|
$96.21M |
|
$96.21M |
|
5.91M |
|
| Cash Flow Statement Financials | |
$-22.39M |
|
-- |
|
$26.90M |
|
$94.85M |
|
|
End Cash |
$99.37M |
$4.52M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-22.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.43% |
|
-16.43% |
|
-15.37% |
|
-16.43% |
|
$16.29 |
|
$-0.56 |
|
$-0.56 |
|